The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

The global Sepsis Treatment Market size was US$ 469 million in 2020. The global Sepsis Treatment Market is forecast to reach US$ 1.7 billion by 2030 by growing at a Compound Annual Growth Rate (CAGR) ...

Nigerians are bracing for more economic weakness after the local currency plunged to a record low against the US dollar. The ...

Sensex, Nifty, Share Prices Highlights: The benchmark equity indices closed on a higher note during Monday’s trading session.

The biotech will now suspend development of a drug prospect that Sanofi acquired partial rights to just four months ago.

The Indian pharmaceuticals market continued to report mid-single-digit growth in August, as sales grew 6.3% annually, ...

As recently as 2016, Swedish Orphan Biovitrum, or Sobi, was largely a specialty pharmaceutical firm in-licensing rights to market drugs in Europe. Since then, the successful launches of hemophilia ...

Given potential NASDAQ weakness and ULTY's high correlation, downside risk exists but may be mitigated by the income component, warranting a cautious hold rating. Analyst’s Disclosure ...

Benchmark equity indices declined in early trade on Friday (September 6, 2024) tracking a weak trend in global markets ... "The near-term trend in the market will be influenced by the US jobs ...

Graham Parry has given his Sell rating due to a combination of factors surrounding GlaxoSmithKline’s recent developments and market competition. Although the pharmaceutical company’s Nucala ...